Cost-effectiveness of liver cancer screening-Reference-Cited by-同舟云学术

Cost-effectiveness of liver cancer screening

Published:2013-12 Issue:6 Volume:27 Page:961-972
ISSN:1521-6918
Container-title:Best Practice & Research Clinical Gastroenterology
language:en
Short-container-title:Best Practice & Research Clinical Gastroenterology

Author:

Cucchetti Alessandro,Cescon Matteo,Erroi Virginia,Pinna Antonio D.

Publisher

Elsevier BV

Subject

Gastroenterology

Reference42 articles.

1. Hepatocellular carcinoma;El Serag;N Engl J Med,2011

2. SEER*Stat database: incidence — SEER 9 Regs research data, Nov 2009 Sub (1973–2007);Surveillance, Epidemiology, and End Results (SEER) Program,2010

3. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis;Ikeda;Hepatology,1993

4. Risk factors for hepatocellular carcinoma among patients with chronic liver disease;Tsukuma;N Engl J Med,1993

5. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis;Velázquez;Hepatology,2003

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimising Surveillance in Hepatocellular Carcinoma: Patient-Defined Obstacles and Solutions;Journal of Hepatocellular Carcinoma;2024-08

2. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-02

3. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-01

4. The clinical and financial burden of nonhepatocellular carcinoma focal lesions detected during the surveillance of patients with cirrhosis;Hepatology;2023-09-29

5. Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology;Nature Reviews Gastroenterology & Hepatology;2023-08-03